Domenico Maione (D Maione)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Binding Protein

Induced Pluripotent Stem Cells

Acute Kidney Injury

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joël Halwe, Lorenz Ulrich, Jacob Schön, Kerstin Wernike, Marek Widera, Sandra Ciesek, Stefan O Mueller, Thomas C Mettenleiter, Domenico Maione, Benjamin Petsch, Martin Beer, Anca Dorhoi
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models. Nature communications 14 (1) (2023)
Nicole Roth, Janina Gergen, Kristina Kovacikova, Stefan O Mueller, Lorenz Ulrich, Jacob Schön, Nico Joël Halwe, Charlie Fricke, Björn Corleis, Anca Dorhoi, Donata Hoffmann, Martin Beer, Domenico Maione, Benjamin Petsch, Susanne Rauch
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models. Vaccines 11 (2) (2023)
Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joël Halwe, Lorenz Ulrich, Jacob Schön, Kerstin Wernike, Marek Widera, Sandra Ciesek, Stefan O Mueller, Thomas C Mettenleiter, Domenico Maione, Benjamin Petsch, Martin Beer, Anca Dorhoi
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models. Nature communications 14 (1) (2023)
Nicole Roth, Janina Gergen, Kristina Kovacikova, Stefan O Mueller, Lorenz Ulrich, Jacob Schön, Nico Joël Halwe, Charlie Fricke, Björn Corleis, Anca Dorhoi, Donata Hoffmann, Martin Beer, Domenico Maione, Benjamin Petsch, Susanne Rauch
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models. Vaccines 11 (2) (2023)
Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joël Halwe, Lorenz Ulrich, Jacob Schön, Kerstin Wernike, Marek Widera, Sandra Ciesek, Stefan O Mueller, Thomas C Mettenleiter, Domenico Maione, Benjamin Petsch, Martin Beer, Anca Dorhoi
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models. Nature communications 14 (1) (2023)
Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joël Halwe, Lorenz Ulrich, Jacob Schön, Kerstin Wernike, Marek Widera, Sandra Ciesek, Stefan O Mueller, Thomas C Mettenleiter, Domenico Maione, Benjamin Petsch, Martin Beer, Anca Dorhoi
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models. Nature communications 14 (1) (2023)
Erika Bartolini, E Borgogni, Marco Bruttini, A Muzzi, M Giuliani, S Iozzi, R Petracca, M Martinelli, Stefano Bonacci, S Marchi, C Brettoni, C Donati, G Torricelli, S Guidotti, M Domina, Concetta Beninati, G Teti, F Felici, Rino Rappuoli, F Castellino, G Del Giudice, V Masignani, M Pizza, Domenico Maione
Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity. Nature communications 11 (1) (2020)
Daniele Veggi, Federica Bianchi, Laura Santini, Paola Lo Surdo, Chelsy C Chesterman, Werner Pansegrau, Nicoletta Bechi, Ying Huang, Vega Masignani, Mariagrazia Pizza, Rino Rappuoli, Matthew James Bottomley, Roberta Cozzi, Domenico Maione
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp. PLoS pathogens 16 (10) (2020)